Wellfully Ltd (WFL) - Total Assets
Based on the latest financial reports, Wellfully Ltd (WFL) holds total assets worth AU$3.51 Million AUD (≈ $2.49 Million USD) as of December 2023. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Wellfully Ltd - Total Assets Trend (1998–2022)
This chart illustrates how Wellfully Ltd's total assets have evolved over time, based on quarterly financial data. Also see how much is Wellfully Ltd worth for the company's overall valuation and market capitalisation.
Wellfully Ltd - Asset Composition Analysis
Current Asset Composition (December 2022)
Wellfully Ltd's total assets of AU$3.51 Million consist of 85.2% current assets and 14.8% non-current assets. Review debt load of Wellfully Ltd to assess the company's total debt and financial obligations.
| Asset Category | Amount (AUD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 7.7% |
| Accounts Receivable | AU$859.67K | 24.7% |
| Inventory | AU$1.84 Million | 52.8% |
| Property, Plant & Equipment | AU$515.47K | 14.8% |
| Intangible Assets | AU$0.00 | 0.0% |
| Goodwill | AU$0.00 | 0.0% |
Asset Composition Trend (1998–2022)
This chart illustrates how Wellfully Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See WFL stock price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Wellfully Ltd's current assets represent 85.2% of total assets in 2022, a decrease from 96.3% in 1998.
- Cash Position: Cash and equivalents constituted 7.7% of total assets in 2022, down from 74.7% in 1998.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 1998.
- Asset Diversification: The largest asset category is inventory at 52.8% of total assets.
Wellfully Ltd Competitors by Total Assets
Key competitors of Wellfully Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Medpace Holdings Inc
NASDAQ:MEDP
|
USA | $2.06 Billion |
|
Chemclin Diagnostics Co. Ltd. A
SHG:688468
|
China | CN¥1.76 Billion |
|
Genetic Signatures Ltd
AU:GSS
|
Australia | AU$49.04 Million |
|
Sonic Healthcare Ltd
AU:SHL
|
Australia | AU$16.78 Billion |
|
Integral Diagnostics Ltd
AU:IDX
|
Australia | AU$1.43 Billion |
|
Australian Clinical Labs Ltd
AU:ACL
|
Australia | AU$562.50 Million |
|
Healius Ltd
AU:HLS
|
Australia | AU$1.77 Billion |
|
Monash Ivf Group Ltd
AU:MVF
|
Australia | AU$510.21 Million |
Wellfully Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.58 | 0.81 | 4.76 |
| Quick Ratio | 0.22 | 0.30 | 4.76 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | AU$-2.16 Million | AU$-689.80K | AU$2.22 Million |
Wellfully Ltd - Advanced Valuation Insights
This section examines the relationship between Wellfully Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 9.47 |
| Latest Market Cap to Assets Ratio | 0.30 |
| Asset Growth Rate (YoY) | 33.0% |
| Total Assets | AU$3.49 Million |
| Market Capitalization | $1.05 Million USD |
Valuation Analysis
Below Book Valuation: The market values Wellfully Ltd's assets below their book value (0.30x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Wellfully Ltd's assets grew by 33.0% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Wellfully Ltd (1998–2022)
The table below shows the annual total assets of Wellfully Ltd from 1998 to 2022.
| Year | Total Assets | Change |
|---|---|---|
| 2022-12-31 | AU$3.49 Million ≈ $2.47 Million |
+33.03% |
| 2021-12-31 | AU$2.62 Million ≈ $1.85 Million |
-22.75% |
| 2020-12-31 | AU$3.39 Million ≈ $2.40 Million |
+184.68% |
| 2019-12-31 | AU$1.19 Million ≈ $843.09K |
-62.01% |
| 2018-12-31 | AU$3.14 Million ≈ $2.22 Million |
-34.74% |
| 2017-12-31 | AU$4.81 Million ≈ $3.40 Million |
-22.55% |
| 2016-12-31 | AU$6.21 Million ≈ $4.39 Million |
-20.87% |
| 2015-12-31 | AU$7.84 Million ≈ $5.55 Million |
+90.07% |
| 2014-12-31 | AU$4.13 Million ≈ $2.92 Million |
-3.82% |
| 2013-12-31 | AU$4.29 Million ≈ $3.04 Million |
+17.99% |
| 2012-12-31 | AU$3.64 Million ≈ $2.57 Million |
-2.38% |
| 2011-12-31 | AU$3.72 Million ≈ $2.64 Million |
-24.47% |
| 2010-12-31 | AU$4.93 Million ≈ $3.49 Million |
-11.22% |
| 2009-12-31 | AU$5.55 Million ≈ $3.93 Million |
+258.83% |
| 2008-12-31 | AU$1.55 Million ≈ $1.10 Million |
+0.61% |
| 2007-12-31 | AU$1.54 Million ≈ $1.09 Million |
-28.34% |
| 2006-12-31 | AU$2.15 Million ≈ $1.52 Million |
+232.55% |
| 2005-12-31 | AU$645.63K ≈ $456.82K |
-52.69% |
| 2004-12-31 | AU$1.36 Million ≈ $965.50K |
+49.13% |
| 2003-12-31 | AU$914.98K ≈ $647.41K |
+52.59% |
| 2002-12-31 | AU$599.63K ≈ $424.28K |
-77.16% |
| 2001-12-31 | AU$2.62 Million ≈ $1.86 Million |
-51.34% |
| 2000-12-31 | AU$5.39 Million ≈ $3.82 Million |
-52.46% |
| 1999-12-31 | AU$11.35 Million ≈ $8.03 Million |
+32.09% |
| 1998-12-31 | AU$8.59 Million ≈ $6.08 Million |
-- |
About Wellfully Ltd
Wellfully Limited, together with its subsidiaries, engages in the research and development of Dermaportation and ETP transdermal drug delivery technologies. The company operates through two segments, Dermaportation Drug Delivery Technology and Devices. It is involved in the industrialization and supply-chain support for its existing product ranges; and sale and marketing of its own brands REDUIT … Read more